| Name | Title | Contact Details |
|---|
Healthcare Interactive, Inc. (HCIactive) is dedicated to revolutionizing the administration and delivery of healthcare. Through our patented, integrative technology and supplemental ancillary services, we afford clients the freedom, control and energy to provide high-performance plan solutions that mitigate risk and improve member outcomes. Disparate plan functions, such as enrollment and eligibility, incentive management and population health are seamlessly conducted through our single-source, cloud-based platform. The outcome: greater operational efficiency, actionable performance data, increased member participation, and overall reduced healthcare costs. Founded in 2006, HCIactive is the progressive leader in delivering integrated, health plan solutions to TPA`s, brokers, health systems, providers and their customers. Our executive leadership team is comprised of seasoned professionals who have established successful track-records in the healthcare industry with over 85 years of combined experience.
HCA Midwest offers a superior level of medical care with 12 state-of-the-art diagnostic and treatment facilities providing a broad range of emergency, outpatient and wellness services as well as acute- and post-acute care.
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.
Pathways Health Center For is a Sarnia, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ascent Living Communities is a company that operates senior living communities in Colorado, offering independent living, assisted living, and memory care services.